Neurofind Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Methylphenidate HCl

Indications/Uses

ADHD.

Dosage/Direction for Use

Individualized dosage. May increase dose in 18 mg increments at wkly intervals. Max: 72 mg in adult & adolescent; 54 mg in childn. Adult patient new to methylphenidate Initially 18-36 mg once daily in the morning. Adolescent & childn new to methylphenidate 18 mg once daily in the morning. Patient currently using methylphenidate 10-60 mg/day.

Administration

May be taken with or without food: Swallow whole w/ liqd. Do not chew/divide/crush.

Contraindications

Hypersensitivity. Patients w/ glaucoma, hyperthyroidism, severe angina pectoris, cardiac arrhythmia, phaeochromocytoma. Treatment w/ MAOIs or w/in a min of 14 days following discontinuation.

MIMS Class

Other CNS Drugs & Agents for ADHD

ATC Classification

N06BA04 - methylphenidate ; Belongs to the class of centrally-acting sympathomimetics. Used as CNS stimulant.

Regulatory Classification

POM

Presentation/Packing

Form

Neurofind PR tab 18 mg

Packing/Price

1's

Form

Neurofind PR tab 27 mg

Packing/Price

1's

Form

Neurofind PR tab 36 mg

Packing/Price

1's

Form

Neurofind PR tab 54 mg

Packing/Price

1's

Neurofind

methylphenidate

Manufacturer:

Laboratorios Liconsa